Partners

PreciseOnco is driven by a strong European public–private partnership bringing together complementary expertise across the innovation chain. The consortium includes large industry partners and SMEs developing imaging, robotic, and therapeutic technologies; leading university hospitals conducting clinical studies; and organisations specialising in dissemination, education, health economics, and professional engagement.

Together, the partners form a collaborative ecosystem committed to delivering clinically meaningful, scalable, and patient‑focused innovations for the future of cancer care.